-
1
-
-
0032105481
-
Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
-
Sehgal S. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998; 31: 335-340.
-
(1998)
Clin Biochem
, vol.31
, pp. 335-340
-
-
Sehgal, S.1
-
2
-
-
0030894459
-
Synergistic mechanisms by which sirolimus and cyclosporine inhibit rat heart and kidney allograft rejection
-
Stepkowski S, Tian L, Napoli K. Synergistic mechanisms by which sirolimus and cyclosporine inhibit rat heart and kidney allograft rejection. Clin Exp Immunol 1997; 108: 63-68.
-
(1997)
Clin Exp Immunol
, vol.108
, pp. 63-68
-
-
Stepkowski, S.1
Tian, L.2
Napoli, K.3
-
3
-
-
0026583694
-
The effect of rapamycin on kidney function in the Sprague-Dawley rat
-
DiJoseph J, Sharma R, Chang J. The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 1992; 52: 507-513.
-
(1992)
Transplantation
, vol.52
, pp. 507-513
-
-
DiJoseph, J.1
Sharma, R.2
Chang, J.3
-
4
-
-
0025789057
-
Toxicity of rapamycin - A comparative and combination study with cyclosporine at immunotheraeutic dosage in the rat
-
Whiting P, Woo J, Adam B et al. Toxicity of rapamycin -a comparative and combination study with cyclosporine at immunotheraeutic dosage in the rat. Transplantation 1991; 52: 203-208.
-
(1991)
Transplantation
, vol.52
, pp. 203-208
-
-
Whiting, P.1
Woo, J.2
Adam, B.3
-
5
-
-
29544442641
-
Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene
-
Hong M, Hong J, Stepkowski S et al. Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene. Transplant Proc 2005; 37: 4254-4258.
-
(2005)
Transplant Proc
, vol.37
, pp. 4254-4258
-
-
Hong, M.1
Hong, J.2
Stepkowski, S.3
-
6
-
-
0028918672
-
Effect of rapamycin on morphological and functional parameters in the kidney of the rabbit
-
Thliveris JA, Yatscoff RW. Effect of rapamycin on morphological and functional parameters in the kidney of the rabbit. Transplantation 1995; 59: 427-429.
-
(1995)
Transplantation
, vol.59
, pp. 427-429
-
-
Thliveris, J.A.1
Yatscoff, R.W.2
-
7
-
-
0035042276
-
Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations
-
Podder H, Steplowski S, Napoli K et al. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol 2001; 12: 1059-1071.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1059-1071
-
-
Podder, H.1
Steplowski, S.2
Napoli, K.3
-
8
-
-
13144256680
-
The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent
-
Kaplan B, Meier-Kriesche H-U, Napoli KL et al. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent. Clin Pharmacol Therapeut 1998; 63: 48-53.
-
(1998)
Clin Pharmacol Therapeut
, vol.63
, pp. 48-53
-
-
Kaplan, B.1
Meier-Kriesche, H.-U.2
Napoli, K.L.3
-
9
-
-
0034786155
-
Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: A randomized controlled trial
-
Reitamo S, Spuls P, Sassolas B et al. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol 2001; 145: 438-445.
-
(2001)
Br J Dermatol
, vol.145
, pp. 438-445
-
-
Reitamo, S.1
Spuls, P.2
Sassolas, B.3
-
10
-
-
0026694617
-
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
-
International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases
-
Feutren G, Mihatsch M. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl J Med 1992; 326: 1654-1660.
-
(1992)
N Engl J Med
, vol.326
, pp. 1654-1660
-
-
Feutren, G.1
Mihatsch, M.2
-
11
-
-
0030064388
-
The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients
-
Murgia M, Jordan S, Kahan B. The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients. Kidney Int 1996; 49: 209-216.
-
(1996)
Kidney Int
, vol.49
, pp. 209-216
-
-
Murgia, M.1
Jordan, S.2
Kahan, B.3
-
12
-
-
0032573044
-
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation
-
Kahan B, Podbielski J, Napoli K et al. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation 1998; 66: 1040.
-
(1998)
Transplantation
, vol.66
, pp. 1040
-
-
Kahan, B.1
Podbielski, J.2
Napoli, K.3
-
13
-
-
0033610638
-
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial
-
Kahan BD, Julian BA, Pescovitz MD et al. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial. Transplantation 1999; 68: 1526-1532.
-
(1999)
Transplantation
, vol.68
, pp. 1526-1532
-
-
Kahan, B.D.1
Julian, B.A.2
Pescovitz, M.D.3
-
14
-
-
0035956745
-
A worldwide, phase III, randomized, controlled safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts
-
MacDonald AS, for the Rapamune Study Group. A worldwide, phase III, randomized, controlled safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71: 271.
-
(2001)
Transplantation
, vol.71
, pp. 271
-
-
MacDonald, A.S.1
-
15
-
-
33746530366
-
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study
-
Kahan BD, for the US Rapamune Study Group. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet 2000; 356: 194.
-
(2000)
Lancet
, vol.356
, pp. 194
-
-
Kahan, B.D.1
-
16
-
-
10044273197
-
Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival
-
Meier-Kriesche H, Steffen B, Chu A et al. Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival. Am J Transplant 2004; 4: 2058-2066.
-
(2004)
Am J Transplant
, vol.4
, pp. 2058-2066
-
-
Meier-Kriesche, H.1
Steffen, B.2
Chu, A.3
-
17
-
-
23744462171
-
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year
-
Mendez R, Gonwa T, Yang H et al. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation 2005; 80: 303-309.
-
(2005)
Transplantation
, vol.80
, pp. 303-309
-
-
Mendez, R.1
Gonwa, T.2
Yang, H.3
-
18
-
-
0037623477
-
Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients
-
Russ G, Campbell S, Chadban S et al. Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients. Transplant Proc 2003; 35: 10010-11710.
-
(2003)
Transplant Proc
, vol.35
, pp. 10010-11710
-
-
Russ, G.1
Campbell, S.2
Chadban, S.3
-
19
-
-
21644457432
-
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
-
Oberbauer R, Segoloni G, Campistol J et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant Int 2005; 18: 2005.
-
(2005)
Transplant Int
, vol.18
, pp. 2005
-
-
Oberbauer, R.1
Segoloni, G.2
Campistol, J.3
-
20
-
-
3542995706
-
Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation
-
Grinyo J, Campistol J, Paul J et al. Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation. Am J Transplant 2004; 4: 1308-1314.
-
(2004)
Am J Transplant
, vol.4
, pp. 1308-1314
-
-
Grinyo, J.1
Campistol, J.2
Paul, J.3
-
21
-
-
2942534405
-
Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years
-
Mota A, Arias M, Taskinen E et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 2004; 4: 953-961.
-
(2004)
Am J Transplant
, vol.4
, pp. 953-961
-
-
Mota, A.1
Arias, M.2
Taskinen, E.3
-
22
-
-
33645945017
-
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients
-
Stallone G, Infante B, Schena A et al. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 2005; 16: 3755-3762.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 3755-3762
-
-
Stallone, G.1
Infante, B.2
Schena, A.3
-
23
-
-
19244366256
-
Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients
-
Morales J, Wramner L, Kreis H et al. Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients. Am J Transplant 2002; 2: 436-442.
-
(2002)
Am J Transplant
, vol.2
, pp. 436-442
-
-
Morales, J.1
Wramner, L.2
Kreis, H.3
-
24
-
-
7244220158
-
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years
-
Flechner S, Kurian S, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 1776-1785.
-
(2004)
Am J Transplant
, vol.4
, pp. 1776-1785
-
-
Flechner, S.1
Kurian, S.2
Solez, K.3
-
25
-
-
33644889043
-
Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
-
Larson T, Dean P, Stegall M et al. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006; 6: 514-522.
-
(2006)
Am J Transplant
, vol.6
, pp. 514-522
-
-
Larson, T.1
Dean, P.2
Stegall, M.3
-
26
-
-
0034789534
-
Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells
-
Lieberthal W, Fuhro R, Andry CC et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol 2001; 281: F693-F706.
-
(2001)
Am J Physiol
, vol.281
-
-
Lieberthal, W.1
Fuhro, R.2
Andry, C.C.3
-
27
-
-
0346848743
-
Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury
-
Fuller TF, Freise C, Serkova N et al. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003; 76: 1594-1599.
-
(2003)
Transplantation
, vol.76
, pp. 1594-1599
-
-
Fuller, T.F.1
Freise, C.2
Serkova, N.3
-
28
-
-
0038666511
-
Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation
-
McTaggart R, Gottlieb D, Brooks J et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3: 413-423.
-
(2003)
Am J Transplant
, vol.3
, pp. 413-423
-
-
McTaggart, R.1
Gottlieb, D.2
Brooks, J.3
-
29
-
-
0037378763
-
Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use
-
Smith K, Wrenshall L, Nicosia R et al. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 2003; 14: 1037-1045.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 1037-1045
-
-
Smith, K.1
Wrenshall, L.2
Nicosia, R.3
-
30
-
-
4644258361
-
The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low versus high risk for delayed graft function
-
Knight RJ, Kerman RH, Schoenberg L et al. The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low versus high risk for delayed graft function. Transplantation 2004; 78: 904-910.
-
(2004)
Transplantation
, vol.78
, pp. 904-910
-
-
Knight, R.J.1
Kerman, R.H.2
Schoenberg, L.3
|